Patents by Inventor Hong Hwa Lim

Hong Hwa Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240145728
    Abstract: Disclosed is an all-solid-state battery capable of suppressing volume expansion during charging and discharging.
    Type: Application
    Filed: April 10, 2023
    Publication date: May 2, 2024
    Inventors: Hee Soo Kang, Hong Suk Choi, Seon Hwa Kim, Jae Min Lim, Sang Wan Kim
  • Publication number: 20240079599
    Abstract: Disclosed is an anodeless all-solid-state battery which may effectively control local volume expansion due to lithium deposited during charging of the battery. The all-solid-state battery includes an anode current collector, an intermediate layer located on the anode current collector, a solid electrolyte layer located on the intermediate layer, a cathode active material layer located on the solid electrolyte layer and including a cathode active material, and a cathode current collector located on the cathode active material layer. The intermediate layer includes carbon particles and metal particles alloyable with lithium, and the carbon particles include a first carbon material, e.g., as a spherical carbon material, and a second carbon material, e.g., a linear carbon material.
    Type: Application
    Filed: April 25, 2023
    Publication date: March 7, 2024
    Applicants: Hyundai Motor Company, Kia Corporation
    Inventors: Young Jin Nam, Hong Suk Choi, Seon Hwa Kim, Hee Soo Kang, Jae Min Lim, Sang Wan Kim
  • Publication number: 20220315587
    Abstract: Compounds of formula I as defined herein, or pharmaceutically acceptable salts, solvates or derivatives thereof, are potent inhibitors of angiogenesis and accordingly are of use in the treatment and prevention of various angiogenesis-related disorders such as macular degeneration and diabetic retinopathy.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 6, 2022
    Inventors: Srinivasaraghavan KANNAN, Hong Hwa LIM, Chandra Shekhar VERMA, Uttam SURANA
  • Publication number: 20220242863
    Abstract: Compounds of formula I as defined herein, or pharmaceutically acceptable salts, solvates or derivatives thereof, are potent inhibitors of angiogenesis and accordingly are of use in the treatment and prevention of various angiogenesis-related disorders such as cancer.
    Type: Application
    Filed: June 25, 2020
    Publication date: August 4, 2022
    Inventors: Srinivasaraghavan KANNAN, Hong Hwa LIM, Chandra Shekhar VERMA, Uttam SURANA
  • Publication number: 20210061800
    Abstract: A compound of formula (I) or a salt, solvate or prodrug thereof: wherein R1 and R4 are independently selected from C1-C5 alkyl, C1-C5 haloalkyl, C1-C5 alkenyl, C1-C5 haloalkenyl, C1-C5 alkynyl, C1-C5 haloalkynyl, C1-C5 alkoxy or C1-C5 haloalkoxy; R2 is an optionally substituted heteroaryl selected from optionally substituted tetrazolyl or optionally substituted imidazopyridinyl; and R3 is selected from H or optionally substituted alkyl.
    Type: Application
    Filed: December 31, 2018
    Publication date: March 4, 2021
    Inventors: Surana UTTAM, Hong Hwa LIM, Chandra VERMA, Srinivasaraghavan KANNAN, Kong Peng LAM, Gireedhar VENKATACHALAM, Shi Qin Vanessa NG
  • Patent number: 8188112
    Abstract: The invention relates to compounds for use in medicine.
    Type: Grant
    Filed: March 31, 2005
    Date of Patent: May 29, 2012
    Assignee: Agency for Science, Technology and Research
    Inventors: Surana Uttam, Vaidehi Krishnan, Anthony Ting, Hong Hwa Lim
  • Publication number: 20090203728
    Abstract: The invention relates to compounds for use in medicine.
    Type: Application
    Filed: March 31, 2005
    Publication date: August 13, 2009
    Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Surana Uttam, Vaidehi Krishnan, Anthony Ting, Hong Hwa Lim